Shifting the Overton Window: enhancing therapeutic outcomes for Māori experiencing Ngā Māuiui kai (eating disorders) through the integration of traditional Māori and Western healing systems in Aotearoa New Zealand

Ngā māuiui kai (eating disorders) are understood within a Māori worldview as a manifestation of imbalance across hinengaro (mind), tinana (body), wairua (spirit) and whānau (family or support system). Prevailing Western treatment, which prioritise biopsychosocial interventions, do not address the cultural and spiritual determinants of health for Māori, creating a gap in culturally responsive care for Māori. This gap is rooted in and sustained by the enduring impacts of colonisation, which marginalised mātauranga Māori (Māori knowledge) and disrupted traditional healing systems. This paper proposes that Specialist Supportive Clinical Management, a flexible, patient-centred psychotherapy, provides a unique point of alignment for the integration of Rongoā Māori, the traditional Māori healing system. Rongoā Māori encompasses modalities such as rongoā rākau (herbal remedies), mirimiri/romiromi (physical therapies), puku kōrero (talk therapy), and karakia (incantations/prayer) and offers a framework embedded within Māori knowledge systems. We argue that rongoā-informed Specialist Supportive Clinical Management, where puku kōrero aligns with Specialist Supportive Clinical Management patient-led dialogue, can synergistically support biopsychosocial goals while ensuring a holistic, culturally grounded approach. This conceptual analysis proposes a culturally adapted intervention to enhance therapeutic engagement, improve health outcomes, and honour the treatment aspirations of Māori by addressing the whole person within their cultural context.

Validation of a criterion-based screening and triage pathway for adult ADHD: a prospective observational study of safety and operational efficiency

BackgroundThe increasing demand for adult attention-deficit hyperactivity disorder (ADHD) assessments has required the development of efficient triage pathways. This study provides a formal assessment of a criterion-based screening model designed to prioritise patient safety and operational efficiency within a National Health Service (NHS) specialist secondary care setting.MethodsA prospective observational validation design was employed, involving 49 consecutive adults referred for ADHD assessment none of whom had a previous ADHD diagnosis. The Comprehensive ADHD Screening Questionnaire (CASQ), a clinician-administered instrument based on DSM-5 criteria, was utilised by four trained Physician Assistants. To ensure an assessment of triage safety, a universal assessment model was adopted: all participants received a blinded, gold-standard diagnostic assessment (NICE-compliant) regardless of the initial triage recommendation thereby eliminating verification bias. The primary outcome measure was the Number Needed to Harm (NNH), defined as the number of people screened before a single false-negative result occurs.ResultsOf the 48 participants who completed the diagnostic process, six (12.5%) received an ADHD diagnosis. The triage pathway correctly identified all six cases, resulting in a sensitivity of 100.0% (95% CI: 61.0%–100.0%) and an infinite NNH. Specificity was 45.2% (95% CI: 31.2%–59.9%), with a positive predictive value of 20.7%. The pathway permitted 39.6% (n = 19) of referrals to be triaged to alternative pathways rather than full ADHD assessment, potentially saving significant specialist clinician time. Exploratory analyses indicated that score magnitude did not reliably distinguish between true and false positives within the group triaged as appropriate for further assessment.ConclusionsThese preliminary findings suggest that criterion-based screening conducted by appropriately trained non-specialist clinicians can achieve high levels of safety whilst improving service efficiency. The findings support the feasibility of task-shifting models in adult ADHD services, provided that triage thresholds are calibrated to prioritise sensitivity. These results require replication in adequately powered multi-site studies before firm conclusions regarding pathway safety can be drawn. Further research is required to establish inter-rater reliability and cost-effectiveness across diverse clinical settings.

Parsing autism spectrum heterogeneity through fMRI

Nature Neuroscience, Published online: 15 May 2026; doi:10.1038/s41593-026-02269-1

Autism is remarkably heterogeneous, posing a long-standing challenge for linking genetics to brain dynamics. A cross-species study identifies two principal dysconnectivity signatures across 20 mouse models of autism risk, each associated with distinct molecular pathways, and shows analogous connectivity patterns in autistic humans. These results establish a translational framework for biologically grounded fMRI phenotyping.